Zynerba Press Releases

11 Oct 18
Zynerba Pharmaceuticals to Present at the 2018 BIO Investor Forum

26 Sep 18
Zynerba Pharmaceuticals to Present at the Cantor Global Healthcare Conference

31 Aug 18
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference

2 Aug 18
Zynerba Pharmaceuticals Reports Second Quarter 2018 Financial Results and Operational Highlights

1 Aug 18
Zynerba Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference

31 Jul 18
Zynerba Pharmaceuticals to Host Conference Call to Provide Second Quarter 2018 Business Update

20 Jul 18
Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock

19 Jul 18
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock

12 Jul 18
Zynerba Pharmaceuticals Announces New FAB-C Phase 2 Open-Label Data in Patients with Fragile X Syndrome

9 Jul 18
Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial of ZYN002 in Fragile X Syndrome